Evaluation of coagulation status in dogs with naturally occurring canine hyperadrenocorticism

Journal of Veterinary Emergency and Critical Care

Volumn 21, Issue 6, 2011, Pages 625-632

  Klose, Tyler C ^a   Creevy, Kate E ^a   Brainard, Benjamin M ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Cushing's disease; Hypercoagulable; Thrombelastography; Thromboembolism

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

BLOOD CLOTTING FACTOR; CHOLESTEROL; HYDROCORTISONE;

ADRENAL CORTEX HYPERFUNCTION; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; DOG; DOG DISEASE; SCHOOL;

ADRENOCORTICAL HYPERFUNCTION; ANALYSIS OF VARIANCE; ANIMALS; BLOOD COAGULATION FACTORS; CHOLESTEROL; DOG DISEASES; DOGS; HYDROCORTISONE; SCHOOLS, VETERINARY;

EID: 84861446965     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2011.00696.x     Document Type: Article

References (37)

1. Ettinger SJ, Feldman EC. Hyperadrenocorticism in dogs, In: Textbook of Veterinary Internal Medicine: Diseases of the Dog and Cat. Philadelphia: WB Saunders Co; 2010.
2. Feldman EC, Nelson RW, Pedersen D. Canine hyperadrenocorticism (Cushing's syndrome), In: Canine and Feline Endocrinology and Reproduction. Philadelphia: Saunders; 2004.
3. Boswood A, Lamb CR, White RN. Aortic and iliac thrombosis in six dogs. J Small Anim Pract 2000; 41:109-114.
4. Johnson LR, Lappin MR, Baker DC. Pulmonary thromboembolism in 29 dogs: 1985-1995. J Vet Intern Med 1999; 13:338-345.
5. LaRue MJ, Murtaugh RJ. Pulmonary thromboembolism in dogs: 47 cases (1986-1987). J Am Vet Med Assoc 1990; 197:1368-1372.
6. Nichols R. Complications and concurrent disease associated with canine hyperadrenocorticism. Vet Clin North Am Small Anim Pract 1997; 27:309-320.
7. Ramsey CC, Burney DP, Macintire DK, et al. Use of streptokinase in four dogs with thrombosis. J Am Vet Med Assoc 1996; 209:780-785.
8. Burns MG, Kelly AB, Hornof WJ, et al. Pulmonary artery thrombosis in three dogs with hyperadrenocorticism. J Am Vet Med Assoc 1981; 178:388-393.
9. Scavelli TD, Peterson ME, Matthiesen DT. Results of surgical treatment for hyperadrenocorticism caused by adrenocortical neoplasia in the dog: 25 cases (1980-1984). J Am Vet Med Assoc 1986; 189:1360-1364.
10. Wiinberg B, Jensen AL, Rojkjaer R, et al. Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs. Vet Clin Pathol 2005; 34:389-393.
11. Otto CM, Rieser TM, Brooks MB, et al. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000; 217:1500-1504.
12. Marschner CB, Bjørnvad CR, Kristensen AT, et al. Thromboelastography results on citrated whole blood from clinically healthy cats depend on modes of activation. Acta Vet Scand 2010; 52:38-42.
13. Epstein KL, Brainard BM, Lopes MAF, et al. Thrombelastography in 26 healthy horses with and without activation by recombinant human tissue factor. J Vet Emerg Crit Care 2009; 19(1):96-101.
14. Donahue SM, Otto CM. Thromboelastography: a tool for measuring hypercoagulability, hypocoagulability, and fibrinolysis. J Vet Emerg Crit Care 2005; 15:9-16.
15. Benitah N, Feldman EC, Kass PH, et al. Evaluation of serum 17-hydroxyprogesterone concentration after administration of ACTH in dogs with hyperadrenocorticism. J Am Vet Med Assoc 2005; 227:1095-1101.
16. Hill KE, Scott-Moncrieff JCR, Koshko MA, et al. Secretion of sex hormones in dogs with adrenal dysfunction. J Am Vet Med Assoc 2005; 226:556-561.
17. Durila M, Kalincik T, Pacakova Z, et al. Discard volume necessary for elimination of heparin flush effect on thromboelastography. Blood Coagul Fibrinolysis 2010; 21:192-195.
18. Perrotta G, Roberts L, Glazier J, et al. Use of sodium citrate anticoagulant for routine hematology analysis on the CELL-DYN® 4000: an opportunity to enhance efficiency in the clinical laboratory. Lab. Hematol. 1998; 4:156-162.
19. Ross R, Harker L. Hyperlipidemia and atherosclerosis. Science 1976; 193:1094-1100.
20. Shibata J, Hasegawa J, Siemens HJ, et al. Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis. Blood 2003; 101:4416-4422.
21. Sjoberg HE, Blomback M, Granberg PO. Thromboembolic complications, heparin treatment in increase in coagulation factors in Cushing's syndrome. Acta Med Scand 1976; 199:95-98.
22. Dal Bo Zanon R, Fornasiero L, Boscaro M, et al. Clotting changes in Cushing's syndrome: elevated factor VIII activity. Folia Haematol Int Mag Klin Morphol Blutforsch 1983; 110:268-277.
23. La Brocca A, Terzolo M, Pia A, et al. Recurrent thromboembolism as a hallmark of Cushing's syndrome. J Endocrinol Invest 1997; 20:211-214.
24. Casonato A, Pontara E, Boscaro M, et al. Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. Blood Coagul Fibrinolysis 1999; 10:145-151.
25. Small M, Lowe GD, Forbes CD, et al. Thromboembolic complications in Cushing's syndrome. Clin Endocrinol (Oxf) 1983; 19:503-511.
26. McCrath DJ, Cerboni E, Frumento RJ, et al. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005; 100:1576-1583.
27. Jacoby RC, Owings JT, Ortega T, et al. Biochemical basis for the hypercoagulable state seen in Cushing syndrome. Arch Surg 2001; 136:1003-1007.
28. Ambrosi B, Sartorio A, Pizzocaro A, et al. Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma. Exp Clin Endocrinol Diabetes 2000; 108:294-298.
29. Feldman BF, Rasedee A, Feldman EC. Haemostatic abnormalities in canine Cushing's syndrome. Res Vet Sci 1986; 41:228-230.
30. Dal Bo Zanon R, Fornasiero L, Boscaro M, et al. Increased factor VIII associated activities in Cushing's syndrome: a probable hypercoagulable state. Thromb Haemost 1982; 47:116-117.
31. Patrassi GM, Sartori MT, Viero ML, et al. The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state. Blood Coagul Fibrinolysis 1992; 3:789-793.
32. Patrassi GM DBZR, Boscaro M, Martinelli S, et al. Further studies on the hypercoagulable state of patients with Cushing's syndrome. Thromb Haemost 1985; 54:518-520.
33. Feldman BF, Zinkl JG, Jain NC, et al. Essential thrombocythemia and reactive thrombocytosis, In: Schalm's Veterinary Hematology. Baltimore: Lippincott Williams and Wilkins; 2000.
34. Snyder LA NJA, Grindem CB. Thrombocytosis in dogs: a retrospective study. Vet Clin Path 2007; 36:311-318.
35. McNulty SE, Sasso P, Vesci J, et al. Platelet concentrate effects on thromboelastography. J Cardiothorac Vasc Anesth 1997; 11:828-830.
36. Ortega TM, Feldman EC, Nelson RW, et al. Systemic arterial blood pressure and urine protein/creatinine ratio in dogs with hyperadrenocorticism. J Am Vet Med Assoc 1996; 209:1724-1729.
37. Goy-Thollot I, Pechereau D, Keroack S, et al. Investigation of the role of aldosterone in hypertension associated with spontaneous pituitary-dependent hyperadrenocorticism in dogs. J Small Anim Pract 2006; 43:489-492.